肠内营养联合益生菌对中重度溃疡性结肠炎的疗效

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (547 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the therapeutic effects of enteral nutrition combined with probiotics against moderate to severe ulcerative colitis(UC).Methods A total of 85 patients with moderate to severe UC admitted to our hospital between January 2015 and December 2019 were randomly divided into the control group (42 cases) and observation group (43 cases).The control group was treated with probiotics alone while the observation group was treated with enteral nutrition combined with probiotics.The clinical efficacy of the two groups was compared based on the levels of body mass index (BMI),albumin (ALB),hemoglobin (HGB),total protein (TP) and other nutritional status indicators as well as levels of serum endomycin (ET),interleukin 4 (IL-4) and peripheral blood CD4⁺CD5⁺.Results The total effective rate of treatment was 93.02% in the observation group,significantly higher than 76.19% in the control group,so the difference was statistically significant (P<0.05).Levels of BMI,ALB,HGB and TP were higher in both groups after treatment,especially in the observation group,with statistically significant difference (P<0.05).The serum ET level in the observation group was lower than of the control group,but the serum levels of IL-4 and CD4⁺CD5⁺ in peripheral blood were higher,with statistically significant difference (P<0.05).Conclusions Enteral nutrition combined with probiotics is effective in the treatment of moderate to severe UC,which can improve the nutritional status of patients,regulate their immune function,and is worthy of clinical application.

Key words： ulcerative colitis enteral nutrition probiotics curative effect nutritional status immune function

Received: 20 March 2020

ZTFLH:

R459.3

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2020/V31/I11/973

[1]	李明松,刘占举,董卫国,等.关于炎症性肠病患者有效预防和治疗SARS-CoV-2感染的共识[J].现代消化及介入诊疗,2020,12(2):146-149.
[2]	郭涛,杨爱明,周炜洵,等.溃疡性结肠炎窄带光成像肠镜下黏膜血管形态对炎症和血管生成的预测价值[J].中华消化内镜杂志,2020,37(4):239-244.
[3]	Loftus E V,Colombel J F,Feagan B G,et al.Long-term efficacy of vedolizumab for ulcerative colitis[J].J Crohns,2016,12(4):4-9.
[4]	黄辉文,王艺霖,王锦琼.益生菌治疗对溃疡性结肠炎患者疗效及肠屏障功能的影响[J].国际医药卫生导报,2018,24(23):3655.
[5]	中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2018年·北京)[J].中国实用内科杂志,2018,38(9):796-813.
[6]	曹卉,王伟,卢锐锋,等.活动期与缓解期溃疡性结肠炎患者黏膜主要菌群研究[J].中华实验外科杂志,2016,33(4):1109-1112.
[7]	Soetikno R M,Mrad R,Pao V,et al.Quality of life research on the internet:feasibility and potential biases in patients with ulcerative colitis[J].J Am Med Inform Assoc,2016,4(6):426-435.
[8]	Brta C,Dlt C,Eugf B,et al.Effects of current parenteral nutrition treatment on health-related quality of life,physical function,nutritional status,survival and adverse events exclusively in patients with advanced cancer:a systematic literature review[J].Crit Rev Oncol Hematol,2019,139:96-107.
[9]	吴慧博,赵海英,朱圣韬,等.不同营养素对活动期溃疡性结肠炎患者肠道生物屏障的影响[J].首都医科大学学报,2019,40(4):635-639.
[10]	杜小东,罗利飞.溃疡性结肠炎患者肠道菌群和肠黏膜屏障的变化及益生菌的干预作用[J].中国微生态学杂志,2019,31(2):412-414.
[11]	王凤纤,缪应雷,张雪芹,等.中重度溃疡性结肠炎患者肠内营养支持治疗的回顾性分析[J].胃肠病学,2019,24(4):235-238.
[12]	邵晓晓,曹佳乐,俞玲敏,等.英夫利西单抗联合肠内营养在中重度溃疡性结肠炎治疗中的临床价值[J].温州医科大学学报,2018,48(9):984-987.
[13]	薄茂林,薛芝兰,张涛.3种益生菌制剂联合美沙拉秦口服治疗轻中度溃疡性结肠炎疗效[J].武警医学,2017,28(10):14-18.
[14]	汪海军.免疫肠内营养联合药物治疗溃疡性结肠炎的效果分析[J].实用中西医联合临床,2017,17(11):128-129.
[15]	黄朝玲,夏宣平,郭旭日,等.能全力在溃疡性结肠炎患者中的营养支持的应用研究[J].中国现代医生,2016,54(16):13-16.